OLYSIO (Janssen Products LP)
Welcome to the PulseAid listing for the OLYSIO drug offered from Janssen Products LP. This Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Products LP |
| NON-PROPRIETARY NAME: | simeprevir |
| SUBSTANCE NAME: | SIMEPREVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-11-22 |
| END MARKETING DATE: | 0000-00-00 |
OLYSIO HUMAN PRESCRIPTION DRUG Details:
| Item Description | OLYSIO from Janssen Products LP |
| LABELER NAME: | Janssen Products LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2013-11-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59676-225_03cb3b41-7b64-4266-9f82-83cb4550426a |
| PRODUCT NDC: | 59676-225 |
| APPLICATION NUMBER: | NDA205123 |
Other SIMEPREVIR Pharmaceutical Manufacturers / Labelers:
